Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Insulin Therapy in Cardiac Surgery
NCT00282698Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Jul 2004
- Primary completion
- May 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of human insulin in hyperglycemia (2 arms), sponsored by Mayo Clinic. Primary endpoints: Mortality at 30 days, Sternal wound infections at 30 days and 4 more. Started Jul 2004; status: completed.
02
Drugs
human insulin
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on NCT00282698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00282698.